Credit Agricole and Northern Trust Corp have sold off significant shareholdings in Humana Inc while Dimensional Fund Advisors, Korea Investment Corp, Sector Gamma AS and Public Sector Pension Investment Board are among entities that have increased their stakes. The stock has seen a 6.5% return on its 6-day streak of gains and shows strong momentum, according to multiple analyses. However, opinions on Humana's stock are mixed, as attested by the average 'Hold' recommendation from analysts. Kubrick Rossin Wealth and Sumitomo Mitsui Financial Group have also initiated positions in Humana Inc. A Humana study reveals a 28% higher treatment success rate for heart failure under value-based care. Although there has been some instability with regards to the company's stock, the general sentiment appears to be positive. Earnings estimates predict a positive outlook, and despite a drop in the Medicare Advantage Membership, the company has raised its outlook. Furthermore, indicators suggest strong revenues and positive growth outlook.Humana has faced challenges with a failed bid to reverse Medicare Bonus cuts and a downgrade in Medicare 'star' ratings. Nevertheless, the healthcare giant has made significant strides in innovation, such as simplifying access to coverage and care information and reducing prior authorization requirements. Further, Humana has devised a new tech solution aiding doctors in treating diabetic patients more effectively.
Humana HUM News Analytics from Tue, 04 Feb 2025 08:00:00 GMT to Sat, 23 Aug 2025 11:55:56 GMT -
Rating 5
- Innovation 3
- Information 5
- Rumor -3
